Clinical Trials
3 trialsNCT06812260 2026-05-20
A Single-arm, Open-label, Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of HLX10 + Chemotherapy in Patients With ES-SCLC
Shanghai Henlius Biotech
Phase 2 Active not recruiting
NCT07321574 2026-01-07
ABP1011T-03
Shanghai AB PharmaTech Ltd.
Phase 2 Recruiting
NCT04221529 2025-09-08
SPACE
AIO-Studien-gGmbH
Phase 2 Completed